MovDisordV3, PascalFrancis, Curation, bibRecord, 002E37

Sulpiride-induced tardive dystonia

Identifieur interne : 002E37 ( PascalFrancis/Curation ); précédent : 002E36; suivant : 002E38

Sulpiride-induced tardive dystonia

Auteurs : L. G. Miller ; J. Jankovic

Source :

Movement disorders [ 0885-3185 ] ; 1990.

RBID : Pascal:90-0168298

Descripteurs français

Pascal (Inist)
- Sulpiride, Antagoniste dopamine, Récepteur dopaminergique D2, Antidépresseur, Homme, Dystonie, Tardif, Psychotrope, Toxicité, Système nerveux pathologie, Etude cas.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antidepressant agent, Case study, D2 Dopamine receptor, Dopamine antagonist, Dystonia, Human, Late, Nervous system diseases, Psychotropic, Toxicity.

Abstract

We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 5`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Sulpiride-induced tardive dystonia`
A11	`01`	`1`		`@1 MILLER (L. G.)`
A11	`02`	`1`		`@1 JANKOVIC (J.)`
A14	`01`			`@1 Baylor coll. medicine, dep. family medicine @2 Houston TX 77030 @3 USA @Z A11011000`
A20				`@1 83-84`
A21				`@1 1990`
A23	`01`			`@0 ENG`
A43	`01`			`@1 CNRS @2 20953`
A44				`@0 0000`
A45				`@0 19 ref.`
A47	`01`	`1`		`@0 90-0168298`
A60				`@1 P`
A61				`@0 A`
A64		`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy`
C02	`01`	`X`		`@0 002B02U01`
C03	`01`	`X`	`FRE`	`@0 Sulpiride`
C03	`02`	`X`	`FRE`	`@0 Antagoniste dopamine`
C03	`03`	`X`	`FRE`	`@0 Récepteur dopaminergique D2`
C03	`04`	`X`	`FRE`	`@0 Antidépresseur`
C03	`05`	`X`	`FRE`	`@0 Homme`
C03	`06`	`X`	`FRE`	`@0 Dystonie`
C03	`07`	`X`	`FRE`	`@0 Tardif`
C03	`15`	`X`	`FRE`	`@0 Psychotrope`
C03	`16`	`X`	`FRE`	`@0 Toxicité`
C03	`17`	`X`	`FRE`	`@0 Système nerveux pathologie`
C03	`18`	`X`	`FRE`	`@0 Etude cas`
C03	`02`	`X`	`ENG`	`@0 Dopamine antagonist`
C03	`03`	`X`	`ENG`	`@0 D2 Dopamine receptor`
C03	`04`	`X`	`ENG`	`@0 Antidepressant agent`
C03	`05`	`X`	`ENG`	`@0 Human`
C03	`06`	`X`	`ENG`	`@0 Dystonia`
C03	`07`	`X`	`ENG`	`@0 Late`
C03	`15`	`X`	`ENG`	`@0 Psychotropic`
C03	`16`	`X`	`ENG`	`@0 Toxicity`
C03	`17`	`X`	`ENG`	`@0 Nervous system diseases`
C03	`18`	`X`	`ENG`	`@0 Case study`
C03	`02`	`X`	`SPA`	`@0 Antagonista dopamina`
C03	`03`	`X`	`SPA`	`@0 Receptor dopaminérgico D2`
C03	`04`	`X`	`SPA`	`@0 Antidepresor`
C03	`05`	`X`	`SPA`	`@0 Hombre`
C03	`06`	`X`	`SPA`	`@0 Distonía`
C03	`07`	`X`	`SPA`	`@0 Tardío`
C03	`15`	`X`	`SPA`	`@0 Psicotropo`
C03	`16`	`X`	`SPA`	`@0 Toxicidad`
C03	`17`	`X`	`SPA`	`@0 Sistema nervioso patología`
C03	`18`	`X`	`SPA`	`@0 Estudio caso`
C04	`01`	`X`		`@0 PU01!16,06,07`
C04	`02`	`X`		`@0 PU06,07!16,01`
N21				`@1 009`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003988

Links to Exploration step

Pascal:90-0168298

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Sulpiride-induced tardive dystonia</title>
<author><name sortKey="Miller, L G" sort="Miller, L G" uniqKey="Miller L" first="L. G." last="Miller">L. G. Miller</name>
</author>
<author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J." last="Jankovic">J. Jankovic</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">90-0168298</idno>
<date when="1990">1990</date>
<idno type="stanalyst">PASCAL 90-0168298 INIST</idno>
<idno type="RBID">Pascal:90-0168298</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003988</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002E37</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Sulpiride-induced tardive dystonia</title>
<author><name sortKey="Miller, L G" sort="Miller, L G" uniqKey="Miller L" first="L. G." last="Miller">L. G. Miller</name>
</author>
<author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J." last="Jankovic">J. Jankovic</name>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1990">1990</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antidepressant agent</term>
<term>Case study</term>
<term>D2 Dopamine receptor</term>
<term>Dopamine antagonist</term>
<term>Dystonia</term>
<term>Human</term>
<term>Late</term>
<term>Nervous system diseases</term>
<term>Psychotropic</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Sulpiride</term>
<term>Antagoniste dopamine</term>
<term>Récepteur dopaminergique D2</term>
<term>Antidépresseur</term>
<term>Homme</term>
<term>Dystonie</term>
<term>Tardif</term>
<term>Psychotrope</term>
<term>Toxicité</term>
<term>Système nerveux pathologie</term>
<term>Etude cas</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>5</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Sulpiride-induced tardive dystonia</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MILLER (L. G.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>JANKOVIC (J.)</s1>
</fA11>
<fA14 i1="01"><s1>Baylor coll. medicine, dep. family medicine</s1>
<s2>Houston TX 77030</s2>
<s3>USA</s3>
<sZ>A11011000</sZ>
</fA14>
<fA20><s1>83-84</s1>
</fA20>
<fA21><s1>1990</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>CNRS</s1>
<s2>20953</s2>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>19 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>90-0168298</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02U01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Sulpiride</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Antagoniste dopamine</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Antidépresseur</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Dystonie</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Tardif</s0>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Psychotrope</s0>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Toxicité</s0>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Etude cas</s0>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dopamine antagonist</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Antidepressant agent</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Dystonia</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Late</s0>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Psychotropic</s0>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Toxicity</s0>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC03>
<fC03 i1="18" i2="X" l="ENG"><s0>Case study</s0>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Antagonista dopamina</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Antidepresor</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Distonía</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Tardío</s0>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Psicotropo</s0>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Toxicidad</s0>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC03>
<fC03 i1="18" i2="X" l="SPA"><s0>Estudio caso</s0>
</fC03>
<fC04 i1="01" i2="X"><s0>PU01!16,06,07</s0>
</fC04>
<fC04 i1="02" i2="X"><s0>PU06,07!16,01</s0>
</fC04>
<fN21><s1>009</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E37 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002E37 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:90-0168298
   |texte=   Sulpiride-induced tardive dystonia
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Sulpiride-induced tardive dystonia

Sulpiride-induced tardive dystonia

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri